Login

Sandro Tobler, VP of Fiber Optic Technology and Operations, shares his experience working at HUBER+SUHNER. 00:10:00

Share On Facebook Share On Twitter

Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Navigating the landscape of medical cannabis opportunities and risks with insights from industry experts |Josh Fegan, CEO,Althea Group.
00:10:00
The Foundation of Successful Investing: Insights from Allodium Investment Consultants | David J. Bromelkamp - CEO of Allodium Investment Consultants
00:10:00
Crescent Capital Group – Capital Markets' | Majid Jafar, CEO, Crescent SAOPTI:BRU
00:10:00
Reyna Silver Corp.: High-Grade Silver Exploration in Historic Mexican District
00:10:00
Palsatech's Riku Aho Discusses Company Operations on RTL7's 'Business in Europe
00:10:00
The explosion of fintech innovation and the mass migration to digital channels|Kabir Kumar,Director,Flourish Ventures
00:10:00
Adapting to the New Financial Landscape: Insights from Janus Henderson's CEO | Ali Dibadj , CEO , Janus Henderson.
00:10:00
How the Pemba Program Enhanced My Business Acumen in Healthcare
00:10:00
Exploring Gold Opportunities: A Conversation with Martin Palasek, CEO of Samo Gold
00:10:00
To honor the occasion, Neil Schrimsher, CEO & President of Applied Industrial Technologies, will ring The Closing Bell at the NYSE​|Neil Schrimsher, CEO & President of Applied Industrial Technologies
00:00:00
Andrew Kruse, Ph.D. Professor of Biological Chemistry and Molecular Pharmacology, HMS| Molecular Activity Behind Human Physiology and Disease
00:10:00
The Evolution of Habeas Corpus from Magna Carta to the English Habeas Corpus Act of 1679|Amanda Tyler

© 2017 - Neuhu+